All In Biotech

Drug Trial Radar · NCT06548542

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease

Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 590 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

590

Planned (sponsor's estimate)

Start

Sep 4, 2024

Primary completion

Jan 2030

Study completion Jan 2030

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Aug 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms including belly pain, diarrhea, tiredness, and weight loss. Treatments are available but do not work the same for all patients or may stop working over time. This study will evaluate the effectiveness and adverse events of targeted therapies (TaTs) for adult participants with moderate to severe CD. The medicines assessed in this study are risankizumab, trosunilimab, lutikizumab, and ABBV-8736. When participants join the study, they will be randomized into available study treatment groups. Adult participants with CD will be enrolled. Around 590 participants will be enrolled in the study at approximately 300 sites worldwide. Risankizumab and trosunilimab are given as an injection under the skin or as an infusion into the vein. Lutikizumab is given as an injection under the skin. ABBV-8736 is given as an infusion into the vein. There may be higher treatment burden for participants in this trial compared to their standard of care treatment without participating in this study. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, endoscopies, checking for side effects and completing questionnaires and a daily diary.

Conditions

  • Crohn's Disease

Interventions

  • RisankizumabDrug

    Subcutaneous Injection

  • LutikizumabDrug

    Subcutaneous Injection

  • TrosunilimabDrug

    Intravenous Infusion

  • RisankizumabDrug

    Intravenous Infusion

  • TrosunilimabDrug

    Subcutaneous Injection

  • ABBV-8736Drug

    Intravenous Infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants who Achieve Endoscopic RemissionTime frame: Week 12
  2. Number of Participants with Adverse Events (AEs)Time frame: Up to approximately 96 weeks

Locations

255 sites in 33 countries. Site status is shown where the registry gives one.

  • Digestive Health Specialists /ID# 266216

    Dothan, Alabama · Recruiting

  • East View Medical Research /ID# 270377

    Mobile, Alabama · Recruiting

  • Southern California Res. Ctr /ID# 265549

    Coronado, California · Recruiting

  • UC San Diego Health System /ID# 265565

    La Jolla, California · Recruiting

  • uc davis medical center - patient support services building /ID# 265554

    Sacramento, California · Recruiting

  • Clinical Applications Laboratories - San Diego - 3rd Avenue /ID# 267391

    San Diego, California · Completed

  • Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 265557

    Colorado Springs, Colorado · Recruiting

  • Danbury Hospital, Western Connecticut Health Network /ID# 265556

    Danbury, Connecticut · Recruiting

  • Yale University School of Medicine /ID# 266786

    New Haven, Connecticut · Recruiting

  • Novum Research /ID# 278128

    Clermont, Florida · Recruiting

  • University of Florida College of Medicine /ID# 266930

    Gainesville, Florida · Recruiting

  • Nature Coast Clinical Research - Inverness /ID# 265874

    Inverness, Florida · Recruiting

  • Atlantic Medical Research /ID# 266207

    Margate, Florida · Recruiting

  • A Plus Research /ID# 265878

    Miami, Florida · Recruiting

  • Sanchez Clinical Research /ID# 265887

    Miami, Florida · Recruiting

  • Advanced Research Institute, Inc /ID# 265548

    New Port Richey, Florida · Recruiting

  • Hillcrest Medical Research, LLC /ID# 267237

    Orange City, Florida · Recruiting

  • Endoscopic Research, Inc. /ID# 267211

    Orlando, Florida · Recruiting

  • Gcp Clinical Research /ID# 278126

    Tampa, Florida · Recruiting

  • AdventHealth Medical Group - Tampa - Bruce B Downs Boulevard /ID# 265538

    Tampa, Florida · Recruiting

  • Florida Medical Clinic - Zephyrhills /ID# 267392

    Zephyrhills, Florida · Recruiting

  • Gastroenterology Associates of Central Georgia /ID# 265547

    Macon, Georgia · Recruiting

  • Treasure Valley Medical Research /ID# 267114

    Boise, Idaho · Recruiting

  • University of Chicago Medical Center /ID# 267400

    Chicago, Illinois · Recruiting

  • OSF St. Francis Medical Center /ID# 266973

    Peoria, Illinois · Recruiting

  • Springfield Clinic Main Campus /ID# 267434

    Springfield, Illinois · Recruiting

  • Indiana University Health University Hospital /ID# 278129

    Indianapolis, Indiana · Recruiting

  • University of Kentucky Chandler Medical Center /ID# 265564

    Lexington, Kentucky · Recruiting

  • Metropolitan Gastroenterology Group - Chevy Chase /ID# 265877

    Chevy Chase, Maryland · Recruiting

  • Velocity Clinical Research - Rockville /ID# 267712

    Rockville, Maryland · Completed

  • Lucida Clinical Trials /ID# 266548

    New Bedford, Massachusetts · Recruiting

  • Henry Ford Medical Center - Columbus /ID# 266503

    Novi, Michigan · Recruiting

  • Mayo Clinic-Rochester /ID# 265550

    Rochester, Minnesota · Recruiting

  • GI Associates Research, LLC /ID# 267433

    Columbia, Missouri · Recruiting

  • Bvl Research /ID# 265870

    Liberty, Missouri · Recruiting

  • Washington University /ID# 266938

    St Louis, Missouri · Recruiting

  • Vector Clinical Trials /ID# 265561

    Las Vegas, Nevada · Recruiting

  • Nyu Langone Long Island Clinical Research Associates - Lake Success /ID# 265566

    Lake Success, New York · Recruiting

  • Icahn School of Medicine at Mount Sinai /ID# 266857

    New York, New York · Completed

  • Northwell Health-Lenox Hill Hospital /ID# 265527

    New York, New York · Recruiting

Showing 40 of 255 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.